For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Aug. 10 in the British Journal of Dermatology.
For adults with moderate-to-severe atopic dermatitis , dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Aug. 10 in theJoseph F. Merola, M.D., from Brigham and Women's Hospital in Boston, and colleagues conducted a phase 4 randomized, double-blind study to examine the impact of dupilumab treatment on sleep and other patient- and physician-reported outcomes.
"Future analyses will assess the persistence of dupilumab's effect on sleep disturbance through 24 weeks," the authors write.Joseph F Merola et al, Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase 4 randomized double-blinded placebo-controlled DUPISTAD study,
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
I sat my Higher exam in Turkey, then set a British recordOn results day, three teenagers reveal the unusual conditions they studied for their exams under.
Lire la suite »
Canada wildfire map as 30,000 households in British Columbia told to evacuateMore than 35,000 people have been driven out of their homes in British Columbia, forcing the federal government to deploy the military, and the province to declare a state of emergency
Lire la suite »
British Nurse Imprisoned for Life for Murdering 7 BabiesA former British nurse who killed seven babies and attempted to kill six more was sentenced to life in prison.
Lire la suite »